2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 35293700 | Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer. | 2022 Mar 16 | 1 |
| 2 | 27138632 | [Study on the therapy of castration-resistant prostate cancer : Randomized phase II study of abiraterone acetate with LHRH therapy vs. abiraterone acetate without LHRH therapy in patients with progressive chemotherapy-naive castration-resistant prostate cancer (SPARE) - AP 67/11 of the Association of Urogenital Oncology (AUO)]. | 2016 May | 1 |